Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Marrone

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cells|September 28, 2021
PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma CellsMartina Tufano, Paolo D'Arrigo, Massimo D'Agostino, et al.
Biochimica Et Biophysica Acta|August 5, 2015
Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamaseCaitlyn M Rotondo, Laura Marrone, Valerie J Goodfellow, et al.
Journal of the American Chemical Society|February 10, 2010
Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamasesJarrod W Johnson, Michael Gretes, Valerie J Goodfellow, et al.
Frontiers in Pharmacology|April 25, 2024
Metabolic vulnerability of cancer stem cells and their nicheLaura Marrone, Simona Romano, Chiara Malasomma, et al.
Cell Death & Disease|February 13, 2023
FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPPMartina Tufano, Laura Marrone, Chiara D'Ambrosio, et al.
Heliyon|August 22, 2024
Tirofiban prevents the effects of SARS-CoV-2 spike protein on macrophage activation and endothelial cell deathLaura Marrone, Simona Romano, Michele Albanese, et al.
Oncology Research|July 7, 2023
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escapeLaura Marrone, Massimo D'Agostino, Carolina Giordano, et al.
Nature Communications|April 11, 2026
A delayed translocation into the endoplasmic reticulum controls the post-translational modifications of PD-L1Magda Cannata Serio, Fulvia Vitale, Gianluca Scerra, et al.
Cell Death Discovery|April 3, 2025
Exploring the potential of selective FKBP51 inhibitors on melanoma: an investigation of their in vitro and in vivo effectsLaura Marrone, Valeria Di Giacomo, Chiara Malasomma, et al.
Frontiers in Immunology|November 19, 2025
Expression and prognostic value of FKBP51 in Hodgkin lymphomaSilvia Varricchio, Simona Romano, Daniela Russo, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cells|September 28, 2021
PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma CellsMartina Tufano, Paolo D'Arrigo, Massimo D'Agostino, et al.
Biochimica Et Biophysica Acta|August 5, 2015
Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamaseCaitlyn M Rotondo, Laura Marrone, Valerie J Goodfellow, et al.
Journal of the American Chemical Society|February 10, 2010
Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamasesJarrod W Johnson, Michael Gretes, Valerie J Goodfellow, et al.
Frontiers in Pharmacology|April 25, 2024
Metabolic vulnerability of cancer stem cells and their nicheLaura Marrone, Simona Romano, Chiara Malasomma, et al.
Cell Death & Disease|February 13, 2023
FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPPMartina Tufano, Laura Marrone, Chiara D'Ambrosio, et al.
Heliyon|August 22, 2024
Tirofiban prevents the effects of SARS-CoV-2 spike protein on macrophage activation and endothelial cell deathLaura Marrone, Simona Romano, Michele Albanese, et al.
Oncology Research|July 7, 2023
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escapeLaura Marrone, Massimo D'Agostino, Carolina Giordano, et al.
Nature Communications|April 11, 2026
A delayed translocation into the endoplasmic reticulum controls the post-translational modifications of PD-L1Magda Cannata Serio, Fulvia Vitale, Gianluca Scerra, et al.
Cell Death Discovery|April 3, 2025
Exploring the potential of selective FKBP51 inhibitors on melanoma: an investigation of their in vitro and in vivo effectsLaura Marrone, Valeria Di Giacomo, Chiara Malasomma, et al.
Frontiers in Immunology|November 19, 2025
Expression and prognostic value of FKBP51 in Hodgkin lymphomaSilvia Varricchio, Simona Romano, Daniela Russo, et al.
Pageof 3